Efficacy of Nanocurcumin as an Add-On Treatment for Patients Hospitalized with COVID-19: A Double-Blind, Randomized Clinical Trial
Ahmadi et al., International Journal of Clinical Practice, doi:10.1155/2023/5734675
https://c19early.org/ahmadi4.html